Abstract | BACKGROUND: METHODS: Expression of IFN-α/βR-1 and IFN-α/βR-2 in peripheral blood mononuclear cells and in liver tissue was measured by flow cytometry, immunofluorescence, immunohistochemistry and RT-PCR. RESULTS: IFN-α/βR-1 and IFN-α/βR-2 in monocytes and lymphocytes increased in CHB patients. Expression of IFNAR-1 and IFNAR-2 in liver had positive correlation with HBV- DNA in liver tissue. Expression of IFN-α/βR in lymphocytes and monocytes increased in the first month, but then decreased during the subsequent interferon-α2b treatment, patients who had higher levels of IFN-α/βR-2 in monocytes prior to therapy showed better viral response than those with lower levels. CONCLUSIONS: Expression of IFN-α/βR-2 in monocytes can be used as a predictable parameter to evaluate the effect of IFN-α treatment in CHB patients.
|
Authors | Fanli Meng, Jiefei Wang, Jian Ge, Xiaopeng Fan, Bing Wang, Liyan Han, Tatiana Kisseleva, YongHan Paik, David A Brenner, Kai Wang |
Journal | Journal of clinical immunology
(J Clin Immunol)
Vol. 31
Issue 3
Pg. 521-32
(Jun 2011)
ISSN: 1573-2592 [Electronic] Netherlands |
PMID | 21445562
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Viral
- Hepatitis B Surface Antigens
- Hepatitis B e Antigens
- Interferon-alpha
- Receptor, Interferon alpha-beta
|
Topics |
- Adult
- Case-Control Studies
- DNA, Viral
(blood, immunology)
- Female
- Flow Cytometry
- Fluorescent Antibody Technique
- Hepatitis B Surface Antigens
(blood)
- Hepatitis B e Antigens
(blood)
- Hepatitis B virus
(drug effects, immunology, physiology)
- Hepatitis B, Chronic
(blood, drug therapy, immunology, pathology, virology)
- Humans
- Immunohistochemistry
- Interferon-alpha
(administration & dosage, therapeutic use)
- Leukocytes, Mononuclear
(cytology, drug effects, immunology)
- Male
- Middle Aged
- Receptor, Interferon alpha-beta
(blood, genetics, immunology)
- Reverse Transcriptase Polymerase Chain Reaction
- Viral Load
(drug effects)
|